Interestingly, genetically enhanced lipolysis targeted to the heart is sufficient to prevent the HFD-triggered cardiac dysfunctions [26,93], suggesting that HSD causes cardiomyopathy in a tissue-autonomous manner via ectopic lipid storage. This evidence concerns the gene CHST3 and cardiomyopathy.